Skip to main content
Top
Published in: CEN Case Reports 1/2018

01-05-2018 | Case Report

Hemorrhagic shock due to bleeding from an arteriovenous fistula after allograft biopsy in a kidney transplant recipient: a case report

Authors: Akihiro Ryuge, Masahiko Yazawa, Kazuki Kitajima, Ryuto Nakazawa, Hideo Sasaki, Tatsuya Chikaraishi, Yugo Shibagaki

Published in: CEN Case Reports | Issue 1/2018

Login to get access

Abstract

Arteriovenous fistula (AVF) after allograft biopsy occurs in 1.6–8.3% of kidney transplant patients and most cases remain asymptomatic. Here, we report a case of hemorrhagic shock in a kidney transplant recipient following bleeding from an AVF after graft biopsy. Immediate intensive care including angiographic embolization saved the patient and the allograft. A 62-year-old woman with end-stage renal disease caused by diabetic nephropathy underwent ABO-incompatible kidney transplantation. No complications occurred in the early postoperative period. However, serum creatinine levels did not decrease sufficiently and decreased graft diastolic blood flow was noted on ultrasound. Therefore, at 14 days after kidney transplantation, allograft biopsy was performed to elucidate the cause of allograft dysfunction. At 5 days after allograft biopsy, the patient developed hemorrhagic shock caused by bleeding from an AVF in the allograft. We immediately performed angiographic embolization, and her vital signs improved without deterioration in renal function. AVF can cause hemorrhagic shock, and angiographic embolization is effective for treating it.
Literature
1.
go back to reference Nahas WC, Mazzucchi E, Henrique A, Ianhez LE, Saldanha LB, Sabbaga E, et al. Percutaneous needle biopsy of the renal allograft using the automated needle system: evaluation of 87 procedures. J Urol. 1993;150(2 Pt 1):313–5.CrossRefPubMed Nahas WC, Mazzucchi E, Henrique A, Ianhez LE, Saldanha LB, Sabbaga E, et al. Percutaneous needle biopsy of the renal allograft using the automated needle system: evaluation of 87 procedures. J Urol. 1993;150(2 Pt 1):313–5.CrossRefPubMed
2.
go back to reference Boschiero LB, Saggin P, Galante O, Prati GF, Dean P, Longo M, et al. Renal needle biopsy of the transplant kidney: vascular and urologic complications. Urol Int. 1992;48:130–3.CrossRefPubMed Boschiero LB, Saggin P, Galante O, Prati GF, Dean P, Longo M, et al. Renal needle biopsy of the transplant kidney: vascular and urologic complications. Urol Int. 1992;48:130–3.CrossRefPubMed
3.
go back to reference Merkus JW, Zeebregts CJ, Hoitsma AJ, van Asten WN, Koene RA, Skotnicki SH. High incidence of arteriovenous fistula after biopsy of kidney allografts. Br J Surg. 1993;80:310–2.CrossRefPubMed Merkus JW, Zeebregts CJ, Hoitsma AJ, van Asten WN, Koene RA, Skotnicki SH. High incidence of arteriovenous fistula after biopsy of kidney allografts. Br J Surg. 1993;80:310–2.CrossRefPubMed
4.
go back to reference Plainfosse MC, Calonge VM, Beyloune-Mainardi C, Glotz D, Duboust A. Vascular complications in the adult kidney transplant recipient. J Clin Ultrasound. 1992;20:517–27.CrossRefPubMed Plainfosse MC, Calonge VM, Beyloune-Mainardi C, Glotz D, Duboust A. Vascular complications in the adult kidney transplant recipient. J Clin Ultrasound. 1992;20:517–27.CrossRefPubMed
5.
go back to reference Loffroy R, Guiu B, Lambert A, Mousson C, Tanter Y, Martin L, et al. Management of post-biopsy renal allograft arteriovenous fistulas with selective arterial embolization: immediate and long-term outcomes. Clin Radiol. 2008;63:657–65.CrossRefPubMed Loffroy R, Guiu B, Lambert A, Mousson C, Tanter Y, Martin L, et al. Management of post-biopsy renal allograft arteriovenous fistulas with selective arterial embolization: immediate and long-term outcomes. Clin Radiol. 2008;63:657–65.CrossRefPubMed
6.
go back to reference Lorenzen J, Schneider A, Körner K, Regier M, Adam G, Nolte-Ernsting C. Post-biopsy arteriovenous fistula in transplant kidney: treatment with superselective transcatheter embolisation. Eur J Radiol. 2012;81:e721–6.CrossRefPubMed Lorenzen J, Schneider A, Körner K, Regier M, Adam G, Nolte-Ernsting C. Post-biopsy arteriovenous fistula in transplant kidney: treatment with superselective transcatheter embolisation. Eur J Radiol. 2012;81:e721–6.CrossRefPubMed
7.
go back to reference Schwarz A, Hiss M, Gwinner W, Becker T, Haller H, Keberle M. Course and relevance of arteriovenous fistulas after renal transplant biopsies. Am J Transpl. 2008;8:826–31.CrossRef Schwarz A, Hiss M, Gwinner W, Becker T, Haller H, Keberle M. Course and relevance of arteriovenous fistulas after renal transplant biopsies. Am J Transpl. 2008;8:826–31.CrossRef
8.
go back to reference Deane C, Cowan N, Giles J, Walters H, Rifkin I, Severn A, et al. Arteriovenous fistulas in renal transplants: color Doppler ultrasound observations. Urol Radiol. 1992;13:211–7.CrossRefPubMed Deane C, Cowan N, Giles J, Walters H, Rifkin I, Severn A, et al. Arteriovenous fistulas in renal transplants: color Doppler ultrasound observations. Urol Radiol. 1992;13:211–7.CrossRefPubMed
9.
go back to reference Voiculescu A, Brause M, Engelbrecht V, Sandmann W, Pfeiffer T, Grabensee B. Hemodynamically relevant hematuria several months after biopsy of a kidney graft: an unusual cause. Clin Nephrol. 2003;59:217–21.CrossRefPubMed Voiculescu A, Brause M, Engelbrecht V, Sandmann W, Pfeiffer T, Grabensee B. Hemodynamically relevant hematuria several months after biopsy of a kidney graft: an unusual cause. Clin Nephrol. 2003;59:217–21.CrossRefPubMed
10.
go back to reference Tøndel C, Vikse BE, Bostad L, Svarstad E. Safety and complications of percutaneous kidney biopsies in 715 children and 8573 adults in Norway 1988–2010. Clin J Am Soc Nephrol. 2012;7:1591–7.CrossRefPubMedPubMedCentral Tøndel C, Vikse BE, Bostad L, Svarstad E. Safety and complications of percutaneous kidney biopsies in 715 children and 8573 adults in Norway 1988–2010. Clin J Am Soc Nephrol. 2012;7:1591–7.CrossRefPubMedPubMedCentral
11.
go back to reference Whittier WL. Complications of the percutaneous kidney biopsy. Adv Chronic Kidney Dis. 2012;19:179–87.CrossRefPubMed Whittier WL. Complications of the percutaneous kidney biopsy. Adv Chronic Kidney Dis. 2012;19:179–87.CrossRefPubMed
13.
go back to reference Manno C, Strippoli GF, Arnesano L, Bonifati C, Campobasso N, Gesualdo L, et al. Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int. 2004;66:1570–7.CrossRefPubMed Manno C, Strippoli GF, Arnesano L, Bonifati C, Campobasso N, Gesualdo L, et al. Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int. 2004;66:1570–7.CrossRefPubMed
14.
go back to reference Harrison KL, Nghiem HV, Coldwell DM, Davis CL. Renal dysfunction due to an arteriovenous fistula in a transplant recipient. J Am Soc Nephrol. 1994;5:1300–6.PubMed Harrison KL, Nghiem HV, Coldwell DM, Davis CL. Renal dysfunction due to an arteriovenous fistula in a transplant recipient. J Am Soc Nephrol. 1994;5:1300–6.PubMed
15.
go back to reference Topham PS, Chen Y. Renal biopsy. In: Johnson RH, Feehally J, Floege J, editors. Comprehensive clinical nephrology. 5th ed. Philadelphia: Elsevier; 2015. p. 71–8. Topham PS, Chen Y. Renal biopsy. In: Johnson RH, Feehally J, Floege J, editors. Comprehensive clinical nephrology. 5th ed. Philadelphia: Elsevier; 2015. p. 71–8.
16.
go back to reference Rollino C, Garofalo G, Roccatello D, Sorrentino T, Sandrone M, Basolo B, et al. Colour-coded Doppler sonography in monitoring native kidney biopsies. Nephrol Dial Transpl. 1994;9:1260–3. Rollino C, Garofalo G, Roccatello D, Sorrentino T, Sandrone M, Basolo B, et al. Colour-coded Doppler sonography in monitoring native kidney biopsies. Nephrol Dial Transpl. 1994;9:1260–3.
17.
go back to reference Morgan TA, Chandran S, Burger IM, Zhang CA, Goldstein RB. Complications of ultrasound-guided renal transplant biopsies. Am J Transpl. 2016;16:1298–305.CrossRef Morgan TA, Chandran S, Burger IM, Zhang CA, Goldstein RB. Complications of ultrasound-guided renal transplant biopsies. Am J Transpl. 2016;16:1298–305.CrossRef
18.
go back to reference Kim MH, Jun KW, Hwang JK, Kim JI, Chung BH, Choi BS, et al. Risk factors for postoperative bleeding in ABO-incompatible kidney transplantation. Clin Transpl. 2015;29:365–72.CrossRef Kim MH, Jun KW, Hwang JK, Kim JI, Chung BH, Choi BS, et al. Risk factors for postoperative bleeding in ABO-incompatible kidney transplantation. Clin Transpl. 2015;29:365–72.CrossRef
19.
go back to reference Kitajima K, Fuchinoue S, Koyama I, Ishida H, Kimikawa M, Tojimbara T, et al. Embolization for arteriovenous fistula after graft biopsy in renal transplant recipients: is it essential for all cases? Transpl Proc. 2000;32:1911.CrossRef Kitajima K, Fuchinoue S, Koyama I, Ishida H, Kimikawa M, Tojimbara T, et al. Embolization for arteriovenous fistula after graft biopsy in renal transplant recipients: is it essential for all cases? Transpl Proc. 2000;32:1911.CrossRef
20.
go back to reference Fossaceca R, Guzzardi G, Cerini P, Parziale G, Malatesta E, Di Gesù I, et al. Management of postbiopsy arteriovenous fistulas in transplanted kidneys and effectiveness of endovascular treatment: a single-center experience. Ann Vasc Surg. 2014;28:452–6.CrossRefPubMed Fossaceca R, Guzzardi G, Cerini P, Parziale G, Malatesta E, Di Gesù I, et al. Management of postbiopsy arteriovenous fistulas in transplanted kidneys and effectiveness of endovascular treatment: a single-center experience. Ann Vasc Surg. 2014;28:452–6.CrossRefPubMed
Metadata
Title
Hemorrhagic shock due to bleeding from an arteriovenous fistula after allograft biopsy in a kidney transplant recipient: a case report
Authors
Akihiro Ryuge
Masahiko Yazawa
Kazuki Kitajima
Ryuto Nakazawa
Hideo Sasaki
Tatsuya Chikaraishi
Yugo Shibagaki
Publication date
01-05-2018
Publisher
Springer Japan
Published in
CEN Case Reports / Issue 1/2018
Electronic ISSN: 2192-4449
DOI
https://doi.org/10.1007/s13730-017-0279-9

Other articles of this Issue 1/2018

CEN Case Reports 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.